UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Index funds typically provide lower fees and simpler index tracking compared to mutual funds, making them a popular choice for new investors.
22,898 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
In March, fintech headlines are driving volatility and opportunity. SoFi’s latest collaboration with Mastercard on st...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
February brought a sharp move for Applied Digital, with the stock sliding around 19%. This article breaks down what d...
Disney faces a cash flow decline even as streaming profitability edges higher. The market-wide tug-of-war keeps DIS a...
A Trump themed meme coin is drawing attention as its price climbs and trading volume expands. Fans jockey to secure a...
When housing activity ebbs, flooring companies face a turning point. This article explores how a leading flooring com...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...
AI is nearing a dramatic turning point. Wedbush predicts a 2026 inflection, and this article explains what that means...
NVIDIA stunned markets with a trillion-dollar order pipeline, but the stock hardly moved. This piece explains what th...
Geopolitics are shaking energy markets, but savvy investors can find steadiness. This piece explains how Iran roiling...